Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial.
Farina CJ, Davidson MH, Shah PK, Stark C, Lu W, Shirodaria C, Wright T, Antoniades CA, Nilsson J, Mehta NN. Farina CJ, et al. Among authors: davidson mh. Cardiovasc Res. 2024 May 29;120(7):678-680. doi: 10.1093/cvr/cvae057. Cardiovasc Res. 2024. PMID: 38523341 Free PMC article. Clinical Trial. No abstract available.
Cardiorenal Safety of OTC Analgesics.
White WB, Kloner RA, Angiolillo DJ, Davidson MH. White WB, et al. Among authors: davidson mh. J Cardiovasc Pharmacol Ther. 2018 Mar;23(2):103-118. doi: 10.1177/1074248417751070. J Cardiovasc Pharmacol Ther. 2018. PMID: 29421936 Free PMC article. Review.
The use of high-sensitivity assays for C-reactive protein in clinical practice.
Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. Musunuru K, et al. Among authors: davidson mh. Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Nat Clin Pract Cardiovasc Med. 2008. PMID: 18711404 Free PMC article. Review.
Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials.
Nicholls SJ, Nelson AJ, Kastelein JJP, Ditmarsch M, Hsieh A, Johnson J, Curcio D, Kling D, Kirkpatrick CF, Davidson MH. Nicholls SJ, et al. Among authors: davidson mh. Pharmacol Res Perspect. 2024 Dec;12(6):e70010. doi: 10.1002/prp2.70010. Pharmacol Res Perspect. 2024. PMID: 39425271 Free PMC article. Review.
A Randomized, Parallel, Open-Label, Single-Dose and Multiple-Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China.
Zhang J, Cao G, Huo Y, Guarneri LL, Ditmarsch M, Kastelein JJP, Kling D, Hsieh A, Wuerdeman E, Davidson MH. Zhang J, et al. Among authors: davidson mh. J Clin Pharmacol. 2024 Aug 19;65(1):96-107. doi: 10.1002/jcph.6121. Online ahead of print. J Clin Pharmacol. 2024. PMID: 39158261 Free PMC article.
372 results